Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.81% |
AMGEN INC. | AMGN | 6.49% |
REGENERON PHARMACEUTICALS | REGN | 5.11% |
VERTEX PHARMACEUTICALS | VRTX | 4.30% |
GILEAD SCIENCES, INC. | GILD | 3.81% |
MODERNA INC | MRNA | 3.26% |
CORTEVA INC | CTVA | 3.25% |
ASTRAZENECA PLC ADR | AZN | 2.95% |
BIOGEN IDEC, INC. | BIIB | 2.74% |
BIOMARIN PHARMACEUTICAL | BMRN | 2.32% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.31% |
ILLUMINA INC | ILMN | 2.18% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.95% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.95% |
VIATRIS INC | VTRS | 1.87% |
EXACT SCIENCES | EXAS | 1.83% |
SAREPTA THERAPEU | SRPT | 1.74% |
UNITED THERAPEUTICS CORP | UTHR | 1.73% |
NATERA INC | NTRA | 1.72% |
INCYTE CORP | INCY | 1.64% |
INTRA-CELLULAR T | ITCI | 1.58% |
ARGENX SE - ADR | ARGX | 1.54% |
CYTOKINETICS INC | CYTK | 1.50% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.49% |
EXELIXIS, INC. | EXEL | 1.43% |
REVOLUTION MEDICINES INC | RVMD | 1.37% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.35% |
ALKERMES PLC | ALKS | 1.31% |
BIONTECH SE-ADR | BNTX | 1.29% |
MEDPACE HOLDINGS | MEDP | 1.28% |
VAXCYTE INC | PCVX | 1.27% |
IONIS PHARMACEUTICALS, IN | IONS | 1.21% |
ROIVANT SCIENCES LTD | ROIV | 1.19% |
CRISPR THERAPEUTICS AG | CRSP | 1.17% |
HALOZYME THERAPEUTICS INC | HALO | 1.15% |
APELLIS PHARMACE | APLS | 1.14% |
BLUEPRINT MEDICI | BPMC | 1.07% |
INSMED INC | INSM | 1.04% |
BRIDGEBIO PHARMA INC | BBIO | 0.93% |
ULTRAGENYX PHARM | RARE | 0.90% |
AMICUS THERAPEUTICS INC | FOLD | 0.89% |
AXSOME THERAPEUT | AXSM | 0.85% |
PROTHENA CORP PL | PRTA | 0.83% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.79% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.78% |
IMMUNOVANT INC | IMVT | 0.72% |
TG THERAPEUTICS | TGTX | 0.67% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.66% |
PTC THERAPEUTICS | PTCT | 0.65% |
GUARDANT HEALTH INC | GH | 0.65% |
INTELLIA THERAPE | NTLA | 0.65% |
DYNAVAX TECHNOLOGY | DVAX | 0.63% |
KRYSTAL BIOTECH INC | KRYS | 0.61% |
BEAM THERAPEUTICS INC | BEAM | 0.60% |
IRONWOOD PHARMAC | IRWD | 0.53% |
MADRIGAL PHARMAC | MDGL | 0.47% |
AKERO THERAPEUTICS INC | AKRO | 0.44% |
SAGE THERAPEUTIC | SAGE | 0.41% |
NOVAVAX INC | NVAX | 0.33% |
PACIFIC BIOSCIEN | PACB | 0.17% |
Other (Cash, derivatives and other liabilities) | 0.50% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.